Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Article

Ting, David T, Dey, Bimalangshu, Chaudhary, Ahmed et al. (2005). Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). . BLOOD, 106(11), 3665. 10.1182/blood.v106.11.3665.3665

cited authors

  • Ting, David T; Dey, Bimalangshu; Chaudhary, Ahmed; Colby, Christine; Power, Karen; McAfee, Steven; Ballen, Karen; Attar, Eyal; Saidman, Susan; Preffer, Frederick; Sackstein, Robert; Shaffer, Juanita; Sykes, Megan; Spitzer, Thomas R

authors

publication date

  • November 16, 2005

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3201 Cardiovascular Medicine and Haematology
  • 3204 Immunology
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • 6.2 Cellular and gene therapies
  • Cancer
  • Clinical Research
  • Health Disparities
  • Hematology
  • Lymphatic Research
  • Lymphoma
  • Minority Health
  • Orphan Drug
  • Rare Diseases
  • Regenerative Medicine
  • Stem Cell Research
  • Stem Cell Research - Nonembryonic - Human
  • Transplantation

Digital Object Identifier (DOI)

publisher

  • American Society of Hematology

start page

  • 3665

volume

  • 106

issue

  • 11